AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment
Authors: Walenga, JM Hoppensteadt, D Pifarre, R Fox, NL Forman, S Hunninghake, DB Campeau, L Herd, JA Hoogwerf, BJ Hickey, A Probstfield, JL Terrin, ML
Citation: Jm. Walenga et al., The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment, J THROMB TH, 11(2), 2001, pp. 143-149
A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial
Authors: Illingworth, RD Crouse, JR Hunninghake, DB Davidson, MH Escobar, ID Stalenhoef, AFH Paragh, G Ma, PTS Liu, M Melino, MR O'Grady, L Mercuri, M Mitchel, YB
Citation: Rd. Illingworth et al., A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial, CURR MED R, 17(1), 2001, pp. 43-50
Peripheral arterial disease detection, awareness, and treatment in primarycare
Authors: Hirsch, AT Criqui, MH Treat-Jacobson, D Regensteiner, JG Creager, MA Olin, JW Krook, SH Hunninghake, DB Comerota, AJ Walsh, ME McDermott, MM Hiatt, WR
Citation: At. Hirsch et al., Peripheral arterial disease detection, awareness, and treatment in primarycare, J AM MED A, 286(11), 2001, pp. 1317-1324
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Authors: Cleeman, JI Grundy, SM Becker, D Clark, LT Cooper, RS Denke, MA Howard, WJ Hunninghake, DB Illingworth, DR Luepker, RV McBride, P McKenney, JM Pasternak, RC Stone, NJ Van Horn, L Brewer, HB Ernst, ND Gordon, D Levy, D Rifkind, B Rossouw, JE Savage, P Haffner, SM Orloff, DG Proschan, MA Schwartz, JS Sempos, CT Shero, ST Murray, EZ
Citation: Ji. Cleeman et al., Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), J AM MED A, 285(19), 2001, pp. 2486-2497
Reduction of LDL cholesterol in patients with primary hypercholesterolemiaby SCH 48461: Results of a multicenter dose-ranging study
Authors: Dujovne, CA Bays, H Davidson, MH Knopp, R Hunninghake, DB Stein, EA Goldberg, AC Jones, P Lipka, LJ Cuffie-Jackson, C
Citation: Ca. Dujovne et al., Reduction of LDL cholesterol in patients with primary hypercholesterolemiaby SCH 48461: Results of a multicenter dose-ranging study, J CLIN PHAR, 41(1), 2001, pp. 70-78
Cystatin C is an independent predictor of fasting and post-methionine loadtotal homocysteine concentrations among stable renal transplant recipients
Authors: Aras, O Tsai, MY Hanson, NQ Bailey, R Rao, GD Hunninghake, DB
Citation: O. Aras et al., Cystatin C is an independent predictor of fasting and post-methionine loadtotal homocysteine concentrations among stable renal transplant recipients, CLIN CHEM, 47(7), 2001, pp. 1263-1268
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the Post CoronaryArtery Bypass Graft Trial
Authors: White, CW Gobel, FL Campeau, L Knatterud, GL Forman, SA Forrester, JS Geller, NL Herd, JA Hickey, A Hoogwerf, BJ Hunninghake, DB Rosenberg, Y Terrin, ML
Citation: Cw. White et al., Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the Post CoronaryArtery Bypass Graft Trial, CIRCULATION, 104(22), 2001, pp. 2660-2665
Does amlodipine increase cancer incidence? Response
Authors: Pitt, B Byington, RP Furberg, CD Miller, ME Riley, W Hunninghake, DB Mancini, GBJ
Citation: B. Pitt et al., Does amlodipine increase cancer incidence? Response, CIRCULATION, 104(2), 2001, pp. E5-E5
Confusing press releases and the PREVENT study - Response
Authors: Pitt, B Byington, RP Furberg, CD Hunninghake, DB Mancini, GBJ Miller, ME Riley, W
Citation: B. Pitt et al., Confusing press releases and the PREVENT study - Response, CIRCULATION, 104(18), 2001, pp. E95-E95
Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease - The heart and estrogen/progestin replacement study
Authors: Simon, JA Hunninghake, DB Agarwal, SK Lin, F Cauley, JA Ireland, CC Pickar, JH
Citation: Ja. Simon et al., Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease - The heart and estrogen/progestin replacement study, ANN INT MED, 135(7), 2001, pp. 493-501
Postdischarge lipid management of coronary artery disease patients according to the new National Cholesterol Education Program guidelines
Authors: Hunninghake, DB
Citation: Db. Hunninghake, Postdischarge lipid management of coronary artery disease patients according to the new National Cholesterol Education Program guidelines, AM J CARD, 88(8A), 2001, pp. 37K-41K
Roundtable discussion: Therapeutic challenges and deficiencies
Authors: Popma, JJ Hunninghake, DB Arad, Y Blumenthal, RS Boden, WE Selwyn, AP
Citation: Jj. Popma et al., Roundtable discussion: Therapeutic challenges and deficiencies, AM J CARD, 88(8A), 2001, pp. 42K-43K
Lessons from the Post Coronary Artery Bypass Graft study in evaluating andcontrolling technical variability in angiographic trials
Authors: White, CW Campeau, L Canner, P Domanski, M Forrester, JS Gobel, FL Herd, JA Hoogwerf, BJ Hunninghake, DB Knatterud, GL LoPresti, F
Citation: Cw. White et al., Lessons from the Post Coronary Artery Bypass Graft study in evaluating andcontrolling technical variability in angiographic trials, AM J CARD, 87(1), 2001, pp. 40-43
Introduction: Missing the target with lipid-lowering therapy
Authors: Hunninghake, DB McKenney, JM
Citation: Db. Hunninghake et Jm. Mckenney, Introduction: Missing the target with lipid-lowering therapy, AM J M CARE, 6(19), 2000, pp. S992-S996
Achieving more aggressive low-density lipoprotein cholesterol lowering
Authors: Hunninghake, DB McKenney, JM Gotto, AM Mehta, JL Jones, PH
Citation: Db. Hunninghake et al., Achieving more aggressive low-density lipoprotein cholesterol lowering, AM J M CARE, 6(19), 2000, pp. S1008-S1016
Plasma cholesterol: An influencing factor in red blood cell oxygen releaseand cellular oxygen availability
Authors: Buchwald, H Menchaca, HJ Michalek, VN Rohde, TD Hunninghake, DB O'Dea, TJ
Citation: H. Buchwald et al., Plasma cholesterol: An influencing factor in red blood cell oxygen releaseand cellular oxygen availability, J AM COLL S, 191(5), 2000, pp. 490-497
Lipid-altering efficacy and safety of simvastatin 80 mg/day: Worldwide long-term experience in patients with hypercholesterolemia
Authors: Davidson, MH Stein, EA Hunninghake, DB Ose, L Dujovne, CA Insull, W Bertolami, M Weiss, SR Kastelein, JJP Scott, RS Campodonico, S Escobar, ID Schrott, HG Bays, H Stepanavage, ME Wu, M Tate, AC Melino, MR Kush, D Mercuri, M Mitchel, YB
Citation: Mh. Davidson et al., Lipid-altering efficacy and safety of simvastatin 80 mg/day: Worldwide long-term experience in patients with hypercholesterolemia, NUTR MET CA, 10(5), 2000, pp. 253-262
Incorporation of lean red meat into a National Cholesterol Education Program Step I diet: A long-term, randomized clinical trial in free-living persons with hypercholesterolemia
Authors: Hunninghake, DB Maki, KC Kwiterovich, PO Davidson, MH Dicklin, MR Kafonek, SD
Citation: Db. Hunninghake et al., Incorporation of lean red meat into a National Cholesterol Education Program Step I diet: A long-term, randomized clinical trial in free-living persons with hypercholesterolemia, J AM COL N, 19(3), 2000, pp. 351-360
Lipid-altering efficacy and safety of simvastatin 80 mg/day: Long-term experience in a large group of patients with hypercholesterolemia
Authors: Ose, L Davidson, MH Stein, EA Kastelein, JJP Scott, RS Hunninghake, DB Campodonico, S Insull, W Escobar, ID Schrott, HG Stepanavage, ME Wu, M Tate, AC Melino, MR Mercuri, M Mitchel, YB
Citation: L. Ose et al., Lipid-altering efficacy and safety of simvastatin 80 mg/day: Long-term experience in a large group of patients with hypercholesterolemia, CLIN CARD, 23(1), 2000, pp. 39-46
Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease - The ADMIT Study: A randomized trial
Authors: Elam, MB Hunninghake, DB Davis, KB Garg, R Johnson, C Egan, D Kostis, JB Sheps, DS Brinton, EA
Citation: Mb. Elam et al., Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease - The ADMIT Study: A randomized trial, J AM MED A, 284(10), 2000, pp. 1263-1270
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial
Authors: Knatterud, GL Rosenberg, Y Campeau, L Geller, NL Hunninghake, DB Forman, SA Forrester, JS Gobel, FL Herd, JA Hickey, A Hoogwerf, BJ Terrin, ML White, C
Citation: Gl. Knatterud et al., Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial, CIRCULATION, 102(2), 2000, pp. 157
Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events
Authors: Pitt, B Byington, RP Furberg, CD Hunninghake, DB Mancini, GBJ Miller, ME Riley, W
Citation: B. Pitt et al., Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events, CIRCULATION, 102(13), 2000, pp. 1503-1510
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels
Authors: Kastelein, JJP Isaacsohn, JL Ose, L Hunninghake, DB Frohlich, J Davidson, MH Habib, R Dujovne, CA Crouse, JR Liu, MZ Melino, MR O'Grady, L Mercuri, M Mitchel, YB
Citation: Jjp. Kastelein et al., Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels, AM J CARD, 86(2), 2000, pp. 221-223
Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial disease
Authors: Garg, R Elam, MB Crouse, JR Davis, KB Kennedy, JW Egan, D Herd, JA Hunninghake, DB Johnson, WC Kostis, JB Sheps, DS Applegate, WB
Citation: R. Garg et al., Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial disease, AM HEART J, 140(5), 2000, pp. 792-803
Hemostatic effects of 1 mg daily warfarin on post CABG patients
Authors: Walenga, JM Hoppensteadt, D Pifarre, R Cressman, MD Hunninghake, DB Fox, NL Terrin, ML Probstfield, JL
Citation: Jm. Walenga et al., Hemostatic effects of 1 mg daily warfarin on post CABG patients, J THROMB TH, 7(3), 1999, pp. 313-318
Risultati: 1-25 | 26-34